Effects of melatonin on behavioral changes of neonatal rats in a model of cortical dysplasia

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 15, 2013, Pages 2080-2084

  Karadeli, H H ^a   Aktekin, B ^b   Yilmaz, B ^b   Kilic, E ^b   Uzar, E ^c   Aci, A ^b   Bingol, C A ^b  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c DICLE UNIVERSITY   (Turkey)

Author keywords

Behavior; Cortical dysplasia; Melatonin

Indexed keywords

MELATONIN; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR CHANGE; COLD INJURY; CONTROLLED STUDY; CORTICAL DYSPLASIA; DRUG EFFECT; LOCOMOTION; MAZE TEST; NEWBORN; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; RAT; ADVERSE EFFECTS; ANIMAL; ANIMAL BEHAVIOR; COLD; DRUG EFFECTS; MALFORMATIONS OF CORTICAL DEVELOPMENT; MOTOR ACTIVITY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; ANXIETY; BEHAVIOR, ANIMAL; COLD TEMPERATURE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MELATONIN; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; RATS, SPRAGUE-DAWLEY;

EID: 84884215499     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. YOUNG-KUK L, SEONG-RYONG L, CHOONG-YOUNG K. Melatonin attenutes the changes in polyamine levels induced systemic kainate administration in rat brains. J Neurol Sci 2000; 178: 124-131.
2. TAYLOR DC, FALCONAR MA, BRUTON CJ, CORSELLIS JA. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971; 34: 369-387.
3. TAN DX, MANCHESTER LC, TERRON MP, FLORES LJ, REITER RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42. (Pubitemid 44924323)
4. TOMAS-ZAPICO C, COTO-MONTES A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005; 39: 99-104. (Pubitemid 41140746)
5. HUSSON I, MESPLES B, BAC P, VAMECQJ, EVRAND P, GRENNSS Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002; 51: 82-92. (Pubitemid 34027980)
6. WELLIN AK, SVEDIN P, LAPATTO R, SULTAN B, HAGBERG H, GRESSENS P, KJELLMERR I, MALLARD C.Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatric Res 2007; 61: 153-158. (Pubitemid 46146871)
7. TUTUNCULER F, ESKIOCAK S, BASARAN UN, EKUKLU G, AYVAZ S, VATANSEVER U. The protective role of melatonin in experimental hypoxic brain damage. Pediatrics Int 2005; 47: 434-439. (Pubitemid 41169579)
8. GITTO E, KARBOWNIK M, REITER RJ, TAN DX, CUZZOCREA S, CHIURAZZI P, CORDARA S, CORONA G, TRIMARCHI G, BARBERI I. Effects of melatonin treatment in septic newborns. Pediatric Res 2001; 50: 756-760. (Pubitemid 33121647)
9. VANECEK J. Cellular mechanism of melatonin action. Physiol Rev 1998; 78: 687-721.
10. XIKOTA JC, RIAL D, RUTHES D, PEREIRA R, FIGUEIREDO CP, PREDIGER RD, WALZ R. Mild cognitive deficits associated to neocortical microgyria in mice with genetic deletion of cellular prion protein. Brain Res 2008; 1241: 148-156.
11. RIAL D, XIKOTA JC, MIOZZO A, CRUZ VE, PREDIGER RD, WALZ R. Differential gender-related susceptibility to learning and memory deficits in mice submitted to neonatal freezing microgyria model. Brain Res Bull 2009; 79: 177-181.
12. LEON J, ACUNA-CASTRVIJEO D, ESCAMES G, TAN DX, REITER RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38: 1-9. (Pubitemid 40139304)
13. BERGER-SWEENEY J, HOHMANN C. Behavioral consequences of abnormal cortical development: insights into developmental disabilities. Behav Brain Res 1997; 86: 121-142. (Pubitemid 27154256)
14. RAKIC Neuron-glia relationship during granule cell migration in developing cerebellar cortex. J Comp Neurol 1971; 141: 283-312.
15. RAKIC Mode of cell migration to the superficial layers of fetal monkey neocortex. J Comp Neurol 1972; 145: 61-84.
16. BARKOVICH AJ. Pediatric neuroimaging, Lippincott William & Wilkins III, 2000. Edition Chapter 5, p 253-381.
17. KUZNIECKY R, MURRO A, KING D, MORAWETZ R, SMITH J, POWERS R, YAGHMAI F, FAUGHT E, GALLAGHER B, SNEAD OC. Magnetic resonance imaging in childhood intractable partial epilepsies: pathologic correlations. Neurology 1993; 43: 681-687. (Pubitemid 23121956)
18. SMYTH MD, BARBARO NM, BARABAN SC. Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia. Epilepsy Res 2002; 50: 251-264. (Pubitemid 35015209)
19. BENARDETE EA, KRIEGSTEIN AR. Increased excitability and decreased sensitivity to GABA in an animal model of dysplastic cortex. Epilepsia 2002; 43: 970-982. (Pubitemid 35006472)
20. RODRIQUEZ C, MAYO JC, SAINZ RJ. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9. (Pubitemid 38130283)
21. CARDINALI DP, BORFMAN GP, LIOTTA G, PÉREZ LLORET S, ALBORNOZ LE, CUTRERA RA, BATISTA J, ORTEGA GALLO A multifactorial approach employing melatonin to accelerate resynchronization of sleepwake cycle after a 12 timezone westerly transmeridian flight in elite soccer athletes. J Pineal Res 2002; 32: 41-46. (Pubitemid 34123755)
22. CARDINALI D Clinical perspectives for the use of melatonin as a neuroprotective chronobiotic in Alzheimer's disease. Aktual Neurol 2003; 3: 188-204.
23. REITER RJ, MELCHIORRI D, SEWERYNEK E. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18: 1-11.
24. REITER RJ, TAN DX, OSUNA C, GITTO E. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Sci 2000; 7: 444-458.
25. GILAD E, CUZZOCREA S, ZINGARELLI B, SALZMAN AL, SZABÓ C. Melatonin is a scavenger of peroxynitrite. Life Sci 1997; 60: 169-174.
26. TURGUT M, UYANIKGIL Y, ATES U, BAKA M, YURTSEVEN ME. Pinealectomy stimulates and exogenous melatonin inhibits harmful effects of epileptiform activity during pregnancy in the hippocampus of newborn rats: an immunohistochemical study. Childs Nerv Syst 2006; 22: 481-488.